Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | PARL | Q9H300 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL699757 | 0.78 | MGLL (0.36) | MGLLTSHRPARL | |
| SCHEMBL28377582 | 0.74 | MGLL (0.36) | MGLLTSHRPARL | |
| SCHEMBL16699304 | 0.73 | POLB (0.31) | — | |
| SCHEMBL865136 | 0.72 | MGLL (0.40) | MGLLPARL | |
| SCHEMBL17447 | 0.72 | MGLL (0.37) | MGLLPARL | |
| SCHEMBL15321160 | 0.71 | MGLL (0.36) | MGLLPARL | |
| Hno SCHEMBL15321628 | 0.71 | MGLL (0.36) | MGLLPARL | |
| Ethylene Glycol SCHEMBL5712362 | 0.71 | MGLL (0.33) | MGLLTSHR | |
| SCHEMBL13533087 | 0.71 | MGLL (0.32) | MGLL | |
| SCHEMBL21947419 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0785465-A1 | Molecular grafting of carboxyl reactive hardeners to energetically treated polyesters to promote adhesion of layers | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1997-07-23 | — | — | EP | claimed |
| US-20170231228-A1 | SURFACE TREATMENTS | BOVIN NICOLAI VLADIMIROVICH (RU) | 2017-08-17 | — | — | US | disclosed |
| EP-0785465-A1 | Molecular grafting of carboxyl reactive hardeners to energetically treated polyesters to promote adhesion of layers | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1997-07-23 | — | — | EP | disclosed |
| EP-0535999-B1 | Method for hardening gelatin | EASTMAN KODAK CO (US) | 1995-03-29 | — | — | EP | disclosed |
| EP-0383843-B1 | METHOD AND COMPOSITION FOR HARDENING GELATIN COMPOSITIONS | EASTMAN KODAK CO (US) | 1994-08-10 | — | — | EP | disclosed |
| US-5236822-A | METHOD AND COMPOSITION FOR HARDENING GELATIN | EASTMAN KODAK COMPANY (US) | 1993-08-17 | — | — | US | disclosed |
| EP-0535999-A1 | Method for hardening gelatin | EASTMAN KODAK COMPANY (US) | 1993-04-07 | — | — | EP | disclosed |
| EP-0281146-B1 | METHOD AND COMPOSITION FOR HARDENING GELATIN | EASTMAN KODAK COMPANY (US) | 1991-08-07 | — | — | EP | disclosed |
| EP-0383843-A1 | METHOD AND COMPOSITION FOR HARDENING GELATIN COMPOSITIONS. | EASTMAN KODAK CO (US) | 1990-08-29 | — | — | EP | disclosed |
| WO-1990002357-A1 | METHOD AND COMPOSITION FOR HARDENING GELATIN COMPOSITIONS | EASTMAN KODAK COMPANY (US) | 1990-03-08 | — | — | WO | disclosed |
| US-4877724-A | Method and composition for hardening gelatin | EASTMAN KODAK COMPANY (US) | 1989-10-31 | — | — | US | disclosed |
| EP-0281146-A1 | Method and composition for hardening gelatin | EASTMAN KODAK COMPANY (US) | 1988-09-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170231228-A1 | SURFACE TREATMENTS | PHOSPHO1, SGMS2, SGMS1 | MGLL 63/4885TSHR 656/4885PARL 1156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.